| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |